Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...(Financial Times) Pfizer snub triggers recrimination at Astra: “Pfizer’s pursuit of AstraZeneca was hanging by a thread on Monday after its “final” £69.4bn offer was rejected by the UK company, sparking...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...Randall Stephenson, AT&T’s chief executive, pitched his pursuit of the largest US satellite TV service provider as “a unique opportunity that will redefine the video entertainment industry” by deliver content...
...“Obviously, anybody doing business in Europe is watching this situation very, very closely,” Randall Stephenson, chairman of the Business Roundtable and chief executive of AT&T, said this week....
...Pfizer’s $68bn deal to buy Wyeth had a $4.5bn reverse break fee attached....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...In his new role, Mr Landgarten will report to Ros Stephenson and Tom King, co-heads of corporate finance....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition